ResMed Dirección

Dirección controles de criterios 4/4

El CEO de ResMed es Mick Farrell , nombrado en Mar 2013, tiene una permanencia de 11.67 años. compensación anual total es $14.12M, compuesta por 8.3% salario y 91.7% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.31% de las acciones de la empresa, por valor de $109.43M. La antigüedad media del equipo directivo y de la junta directiva es de 2.8 años y 7 años, respectivamente.

Información clave

Mick Farrell

Chief Executive Officer (CEO)

US$14.1m

Compensación total

Porcentaje del salario del CEO8.3%
Permanencia del CEO11.7yrs
Participación del CEO0.3%
Permanencia media de la dirección2.8yrs
Promedio de permanencia en la Junta Directiva7yrs

Actualizaciones recientes de la dirección

Shareholders May Not Be So Generous With ResMed Inc.'s (NYSE:RMD) CEO Compensation And Here's Why

Nov 13
Shareholders May Not Be So Generous With ResMed Inc.'s (NYSE:RMD) CEO Compensation And Here's Why

Recent updates

Shareholders May Not Be So Generous With ResMed Inc.'s (NYSE:RMD) CEO Compensation And Here's Why

Nov 13
Shareholders May Not Be So Generous With ResMed Inc.'s (NYSE:RMD) CEO Compensation And Here's Why

We Think ResMed (NYSE:RMD) Can Manage Its Debt With Ease

Nov 01
We Think ResMed (NYSE:RMD) Can Manage Its Debt With Ease

Here's Why We Think ResMed (NYSE:RMD) Might Deserve Your Attention Today

Oct 20
Here's Why We Think ResMed (NYSE:RMD) Might Deserve Your Attention Today

ResMed Inc.'s (NYSE:RMD) Intrinsic Value Is Potentially 47% Above Its Share Price

Oct 08
ResMed Inc.'s (NYSE:RMD) Intrinsic Value Is Potentially 47% Above Its Share Price

Why ResMed's Rally Is Just Getting Started

Sep 18

ResMed Inc.'s (NYSE:RMD) Earnings Haven't Escaped The Attention Of Investors

Sep 13
ResMed Inc.'s (NYSE:RMD) Earnings Haven't Escaped The Attention Of Investors

ResMed (NYSE:RMD) Is Increasing Its Dividend To $0.53

Aug 05
ResMed (NYSE:RMD) Is Increasing Its Dividend To $0.53

Does ResMed (NYSE:RMD) Have A Healthy Balance Sheet?

Jul 29
Does ResMed (NYSE:RMD) Have A Healthy Balance Sheet?

Returns On Capital Are A Standout For ResMed (NYSE:RMD)

Jul 15
Returns On Capital Are A Standout For ResMed (NYSE:RMD)

ResMed: Asymmetrical Value Opportunity With High Prospect Of Re-Rating

Jul 03

An Intrinsic Calculation For ResMed Inc. (NYSE:RMD) Suggests It's 33% Undervalued

Jul 02
An Intrinsic Calculation For ResMed Inc. (NYSE:RMD) Suggests It's 33% Undervalued

ResMed (NYSE:RMD) Seems To Use Debt Quite Sensibly

Apr 30
ResMed (NYSE:RMD) Seems To Use Debt Quite Sensibly

Earnings Beat: ResMed Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Apr 30
Earnings Beat: ResMed Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

ResMed Inc.'s (NYSE:RMD) Popularity With Investors Is Clear

Apr 18
ResMed Inc.'s (NYSE:RMD) Popularity With Investors Is Clear

With EPS Growth And More, ResMed (NYSE:RMD) Makes An Interesting Case

Mar 22
With EPS Growth And More, ResMed (NYSE:RMD) Makes An Interesting Case

Capital Investments At ResMed (NYSE:RMD) Point To A Promising Future

Mar 10
Capital Investments At ResMed (NYSE:RMD) Point To A Promising Future

An Intrinsic Calculation For ResMed Inc. (NYSE:RMD) Suggests It's 30% Undervalued

Feb 12
An Intrinsic Calculation For ResMed Inc. (NYSE:RMD) Suggests It's 30% Undervalued

Why ResMed Is One Of My Top Picks In 2024

Jan 22

A First Look At ResMed

Jan 09

ResMed Inc.'s (NYSE:RMD) Share Price Could Signal Some Risk

Dec 20
ResMed Inc.'s (NYSE:RMD) Share Price Could Signal Some Risk

Why You Should Care About ResMed's (NYSE:RMD) Strong Returns On Capital

Dec 06
Why You Should Care About ResMed's (NYSE:RMD) Strong Returns On Capital

Shareholders May Find It Hard To Justify Increasing ResMed Inc.'s (NYSE:RMD) CEO Compensation For Now

Nov 10
Shareholders May Find It Hard To Justify Increasing ResMed Inc.'s (NYSE:RMD) CEO Compensation For Now

Are Investors Undervaluing ResMed Inc. (NYSE:RMD) By 41%?

Nov 01
Are Investors Undervaluing ResMed Inc. (NYSE:RMD) By 41%?

ResMed: Weight-Loss Drug Worries Provide Buying Opportunity

Oct 28

ResMed: Stock Re-Rating To 20x Forward P/E Is A Buy Opportunity

Sep 12

ResMed Has Become A Steal (Rating Upgrade)

Aug 10

ResMed's (NYSE:RMD) Shareholders Will Receive A Bigger Dividend Than Last Year

Aug 07
ResMed's (NYSE:RMD) Shareholders Will Receive A Bigger Dividend Than Last Year

ResMed (NYSE:RMD) Has Some Way To Go To Become A Multi-Bagger

Jul 30
ResMed (NYSE:RMD) Has Some Way To Go To Become A Multi-Bagger

Here's Why We Think ResMed (NYSE:RMD) Might Deserve Your Attention Today

Jul 16
Here's Why We Think ResMed (NYSE:RMD) Might Deserve Your Attention Today

Compound Your Wealth With ResMed

Jul 04

A Look At The Fair Value Of ResMed Inc. (NYSE:RMD)

Jul 02
A Look At The Fair Value Of ResMed Inc. (NYSE:RMD)

We Think ResMed (NYSE:RMD) Can Stay On Top Of Its Debt

May 26
We Think ResMed (NYSE:RMD) Can Stay On Top Of Its Debt

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Mick Farrell en comparación con los beneficios de ResMed?
FechaCompensación totalSalarioIngresos de la empresa
Sep 30 2024n/an/a

US$1b

Jun 30 2024US$14mUS$1m

US$1b

Mar 31 2024n/an/a

US$958m

Dec 31 2023n/an/a

US$890m

Sep 30 2023n/an/a

US$907m

Jun 30 2023US$14mUS$1m

US$898m

Mar 31 2023n/an/a

US$863m

Dec 31 2022n/an/a

US$809m

Sep 30 2022n/an/a

US$786m

Jun 30 2022US$12mUS$1m

US$779m

Mar 31 2022n/an/a

US$779m

Dec 31 2021n/an/a

US$522m

Sep 30 2021n/an/a

US$500m

Jun 30 2021US$10mUS$1m

US$475m

Mar 31 2021n/an/a

US$457m

Dec 31 2020n/an/a

US$699m

Sep 30 2020n/an/a

US$680m

Jun 30 2020US$10mUS$1m

US$622m

Mar 31 2020n/an/a

US$513m

Dec 31 2019n/an/a

US$455m

Sep 30 2019n/an/a

US$419m

Jun 30 2019US$10mUS$967k

US$405m

Mar 31 2019n/an/a

US$446m

Dec 31 2018n/an/a

US$450m

Sep 30 2018n/an/a

US$335m

Jun 30 2018US$9mUS$934k

US$316m

Compensación vs. Mercado: La compensación total ($USD14.12M) de Mick está en línea con el promedio de empresas de tamaño similar en el mercado US ($USD12.73M).

Compensación vs. Ingresos: La compensación de Mick ha sido consistente con los resultados de la empresa en el último año.


CEO

Mick Farrell (52 yo)

11.7yrs

Permanencia

US$14,120,829

Compensación

Mr. Michael J. Farrell, also known as Mick, BE, SM, MBA, served as Director of Fullbay, Inc. since May 2023 until 2023. He serves as Member of Advisory Board at Green Sun Medical, LLC. He serves as the Chi...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Michael Farrell
CEO & Chairman11.7yrsUS$14.12m0.31%
$ 109.4m
Peter Farrell
Founderno dataUS$719.69k0.056%
$ 19.7m
Brett Sandercock
Chief Financial Officer18.8yrsUS$3.23m0.065%
$ 22.6m
Michael Rider
Chief Legal Officer & Secretary1.3yrsUS$2.15m0.0064%
$ 2.2m
Justin Leong
Chief Product Officer8.5yrsUS$3.60m0.013%
$ 4.5m
Kaushik Ghoshal
Chief Commercial Officer - SaaS2.8yrsUS$3.53m0.013%
$ 4.6m
Alastair Robertson
Chief Information Officerless than a yearsin datossin datos
Amy Wakeham
Chief Investor Relations Officer1.6yrssin datossin datos
Jim Ellis
Chief Compliance Officer6.8yrssin datossin datos
Yvonne-Katrin Pucknat
Chief Marketing Officerless than a yearsin datossin datos
Vered Keisar
Chief People Officer3.7yrssin datossin datos
Robert Douglas
Special Advisorless than a yearUS$6.67m0%
$ 0

2.8yrs

Permanencia media

57yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de RMD se considera experimentado (2.8 años antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Michael Farrell
CEO & Chairman11.7yrsUS$14.12m0.31%
$ 109.4m
Peter Farrell
Founder35.4yrsUS$719.69k0.056%
$ 19.7m
Richard Sulpizio
Independent Director19.3yrsUS$348.72k0.010%
$ 3.6m
Ronald Taylor
Lead Independent Director19.8yrsUS$381.22k0.014%
$ 5.0m
Jan De Witte
Independent Non-Executive Director5.5yrsUS$329.97k0.0046%
$ 1.6m
Harjit Gill
Independent Director6yrsUS$329.97k0.0060%
$ 2.1m
Carol Burt
Independent Director11yrsUS$369.97k0.010%
$ 3.5m
Karen Drexler
Independent Director7yrsUS$334.97k0.0052%
$ 1.8m
Christopher DelOrefice
Independent Directorless than a yearsin datossin datos
Desney Tan
Independent Director3yrsUS$329.97k0.0014%
$ 496.2k
John Hernandez
Independent Director3yrsUS$329.97k0.0014%
$ 496.2k

7.0yrs

Permanencia media

60yo

Promedio de edad

Junta con experiencia: La junta directiva de RMD se considera experimentada (7 años de antigüedad promedio).